ARS Pharma enters agreement with ALK-Abelló to co-promote neffy, a needle-free treatment for type I allergic reactions: San Diego Monday, May 5, 2025, 12:00 Hrs [IST] ARS Pharmac ...

The species is not aggressive, but they can sting if bothered. And that sting may lead to a potentially fatal allergic ...

Co-promotion with ARS Pharma based on cost sharing and performance-based revenue sharing.ALK to accelerate build-up of its US paediatric sales channel in a balanced way. Agreement does not change ...

Adolescents with food allergy had 2.83 food allergic reactions per 100 person-months, just under half of which met the criteria for anaphylaxis.

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

Medically reviewed by Corinne Savides Happel, MD Allergies occur when your immune system overreacts to harmless substances, ...

Wildlife encounters in the workplace may be uncommon, but they can disrupt operations and pose serious risks. By planning ahead and educating employees, you can minimize these hazards and ensure ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

Schools should not carry more epinephrine auto-injectors than necessary because these medications ... Allergies Act requires school authorities to establish and maintain an anaphylaxis policy and a ...